Company Medicodinu Srl with Fiscal Code 35231458
recorded a turnover of 2024 of
60.778,
with a net profit of
39.676
and having an average number of employees of
1.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Medicodinu Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
0
24.514
71.983
78.216
72.831
63.127
75.404
87.536
79.214
60.778
Total Income - EUR
0
24.514
72.102
78.480
72.832
63.129
75.406
87.624
79.216
60.778
Total Expenses - EUR
11
20.974
19.548
22.705
22.907
19.853
20.517
17.044
18.963
19.315
Gross Profit/Loss - EUR
-11
3.539
52.554
55.775
49.925
43.276
54.889
70.580
60.253
41.463
Net Profit/Loss - EUR
-11
3.049
51.832
55.030
49.342
42.917
54.320
69.867
59.588
39.676
Employees
0
1
1
1
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -22.8%, from 79.214 euro in the year 2023, to 60.778 euro in 2024.
The Net Profit decreased by -19.578 euro, from 59.588 euro in 2023, to 39.676 in the last year.
Check the financial reports for the company - Medicodinu Srl
Financial Rating - MEDICODINU SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Medicodinu Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Medicodinu Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Medicodinu Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
40.450 euro in 2024 which includes Inventories of
808 euro, Receivables of
33.274 euro and cash availability of
6.368 euro.
The company's Equity was valued at
39.724 euro, while total Liabilities amounted to
1.401 euro.
Equity decreased by -19.578 euro, from 59.636 euro in 2023, to 39.724 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Medicodinu Srl